TY  - JOUR 
AU  - Rodríguez de Santiago, Enrique
AU  - Martín de Argila de Prados, Carlos
AU  - Marcos Prieto, Hector Miguel
AU  - Jorge Turrión, Miguel Ãngel
AU  - Barreiro Alonso, Eva
AU  - Flores de Miguel, Alvaro
AU  - de la Coba Ortiz, Cristobal
AU  - Rodríguez Escaja, Carlos
AU  - Pérez Álvarez, Gustavo
AU  - Ferre Aracil, Carlos
AU  - Aguilera Castro, Lara
AU  - García García de Paredes, Ana
AU  - Rodríguez Pérez, Antonio
AU  - Albillos Martínez, Agustin
PY  - 2017
SN  - 1083-4389
UR  - http://hdl.handle.net/10366/146413
AB  - [EN]To assess the effectiveness, safety, and tolerance of Pylera® as a third-line in clinical practice.This was a multicenter, observational, prospective database study in four Spanish hospitals. Consecutive H. pylori-infected individuals treated...
LA  - eng
PB  - Wiley Online Library
KW  - Bismuth
KW  - Helicobacter
KW  - Pylera
KW  - Rescue
KW  - Quadruple therapy
KW  - Third-line
KW  - Bismuth
KW  - Digestive System Diseases
KW  - Helicobacter
TI  - Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera®) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study
DO  - 10.1111/hel.12423
T2  - Helicobacter
VL  - 22
M2  - e12423
ER  -